Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers

Carcinogenesis

Volumn 26, Issue 7, 2005, Pages 1241-1246

  Chen, Shou Tung ^a,b   Choo, Kong Bung ^c   Hou, Ming Feng ^d   Yeh, Kun Tu ^b   Kuo, Shou Jen ^b   Chang, Jan Gowth ^a,e  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e Taipei Institute of Pathology   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HELIX LOOP HELIX PROTEIN; PER1 PROTEIN; PER2 PROTEIN; PROTEIN PER3; THYROID HORMONE RECEPTOR BETA; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; NUCLEAR PROTEIN; PER1 PROTEIN, HUMAN; PER2 PROTEIN, HUMAN; PER3 PROTEIN, HUMAN; PER3 PROTEIN, MOUSE; PER3 PROTEIN, VERTEBRATE; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CELL CYCLE; CELL SURVIVAL; CHRONOTHERAPY; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS; TAIWAN; BIOSYNTHESIS; BREAST TUMOR; DNA METHYLATION; GENE EXPRESSION PROFILING; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL SURVIVAL; CIRCADIAN RHYTHM; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RECEPTOR, ERBB-2; RISK FACTORS; TAIWAN; TRANSCRIPTION FACTORS;

EID: 22844451414     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi075     Document Type: Article

References (43)

1. Devilee,P., Schuuring,E., van de Vijver,M.J. and Cornelisse,C.J. (1995) Recent developments in the molecular genetic understanding of breast cancer. Crit. Rev. Oncog., 5, 247-270.
2. Ronco,A., De Stefani,B., Mendilaharsu,M. and Deneo-Pellegrini,H. (1996) Meat, fat and risk of breast cancer - a case-control study from Uruguay. Int. J. Cancer, 65, 328-331.
3. Ambrosone,C.B., Freudenheim,J.L., Graham,S. et al. (1996) Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms and breast caner risk. J. Am. Med. Assoc., 276, 1494-1501.
4. Magnusson,C., Baron,J., Persson,I., Wolk,A., Bergstrom,R., Trichopoulos,D. and Adami,H.O. (1998) Body size in different periods of life and breast cancer risk in postmenopausal women. Int. J. Cancer 76, 29-34.
5. Hou,M.F., Chen,S.T., Chen,J.C., Yeh,K.T., Lee,T.P., Chen,C.M., Shih,M.C, Lin,C.C. and Chang,J.G. (2002) Sulfotransferase 1A2*2 is a risk factor for early-onset breast cancer. Int. J. Mol. Med., 10, 609-612.
6. Popescu,N.C. and Zimonjic,D.B. (2002) Chromosome and gene alterations in breast cancer as markers for diagnosis and prognosis as well as pathogenetic targets for therapy. Am. J. Med. Genet., 115, 142-149.
7. Perou,C.M., Serlie,T., Eisen,M.B. et al. (2000) Molecular portraits of human breast tumours. Nature, 406, 747-752.
8. Lerebours,F. and Lidereau,R. (2002) Molecular alterations in sporadic breast cancer. Crit. Rev. Oncol. Hematol., 44, 121-141.
9. Widschwendter,M. and Jones,P.A. (2002) DNA methylation and breast carcinogenesis. Oncogene, 21, 5462-5482.
10. Stevens,R.G. and Rea,M.S. (2001) Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control, 12, 279-287.
11. Keith,L.G., Oleszczuk,J.J. and Laguens,M. (2001) Circadian rhythm chaos: a new breast cancer marker. Int. J. Fertil., 46, 238-247.
12. Reppert,S.M. and Weaver,D. R. (2002) Coordination of circadian timing in mammals. Nature, 418, 935-941.
13. Morse,D. and Sassone-Corsi,P. (2002) Time after time: Inputs to and outputs from the mammalian circadian oscillators. Trends Neurosci. 25, 632-637.
14. Balsalobre,A. (2002) Clock genes in mammalian peripheral tissues. Cell Tissue Res., 309, 193-199.
15. Wager-Smith,K. and Kay,S.A. (2000) Circadian rhythm genetics: From flies to mice to humans. Nat. Genet., 26, 23-27.
16. Urs,A. (2002) Functional genomics of sleep and circadian rhythm invited review: Regulation of mammalian circadian clock genes. J. Appl. Physiol., 92, 1348-1355.
17. Allada,R., Emery,P., Takahashi,J.S. and Rosbash,M. (2001) Stopping time: the genetics of fly and mouse circadian clocks. Annu. Rev. Neurosci. 24, 1091-1119.
18. Barnes,J.W., Tischkau,S.A., Barnes,J.A., Mitchell,J.W., Burgoon,P.W., Hickok,J.R. and Gillette,M.U. (2003) Requirement of mammalian timeless for circadian rhythmicity. Science, 302, 439-442.
19. Rafnsson,V., Tulinius,H., Jónasson,J.G. and Hrafnelsson,J. (2001) Risk of breast cancer in female flight attendants: A population-based study (Iceland). Cancer Causes Control, 12, 95-101.
20. Schernhammer,E.S., Laden,F., Speizer,F.E., Willett,W.C., Hunter,D.J., Kawachi,I. and Colditz,G.A. (2001) Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J. Nat. Cancer Inst., 93, 1563-1568.
21. Hansen,J. (2001) Light at night, shiftwork and breast cancer risk. J. Nat. Cancer Inst., 93, 1513-1515.
22. Blask,D.E., Dauchy,R.T., Saucer,L.A., Krause,J.A. and Brainard,G.C. (2003) Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude sats: Impact of constant light-induced nocturnal melatonin suppression. Breast Cancer Res. Treat., 79, 313-320.
23. Su,T.H., Wang,J.C., Tseng,H.H., Chang,C.P., Chang,T.A., Wei,H.J. and Chang,J.G. (1998) Analysis of FHIT transcripts in cervical and endometrial cancers. Int. J. Cancer, 76, 216-222.
24. Chan,T.F., Su,T.H., Yeh,K.T., Chang,J.Y., Lin,T.H., Chen,J.C., Yuang,S.S. and Chang,J.G. (2003) Mutational, epigenetic and expressional analyses of caveolin-1 gene in cervical cancers. Int. J. Oncol. 23, 599-604.
25. Hirota,T., Okano,T., Kokame,K., Shirotani-Ikejima,H., Miyata,T. and Fukada,Y. (2002) Glucose down-regulates Per1 and Per2 mRNA levels and induces circadian gene expression in cultured Rat-1 fibroblasts. J. Biol. Chem., 277, 44244-44251.
26. Oster,H., Werner,C., Magnone,M.C., Mayser,H., Feil,R., Seeliger,M.W., Hofmann,F. and Albrecht,U. (2003) cGMP-dependent protein kinase II modulates mPer1 and mPer2 gene induction and influences phase shifts of the circadian clock. Curr. Biol., 13, 725-733.
27. Masumoto,K.H., Fujioka,A., Nakahama,K., Inouye,S.T. and Shigeyoshi,Y. (2003) Effect of phosphodiesterase type 4 on circadian clock gene Per1 transcription. Biochem. Biophys. Res. Commun., 306, 781-785.
28. Motzkus,D., Albrecht,U. and Maronde,E. (2002) The human PER1 gene is inducible by interleukin-6. J. Mol. Neurosci., 18, 105-109.
29. Motzkus,D., Maronde,E., Grunenberg,U., Lee,C.C., Forssmann,W. and Albrecht,U. (2000) The human PER1 gene is transcriptionally regulated by multiple signaling pathways. FEBS. Lett., 486, 315-319.
30. Cermakian,N., Monaco,L., Pando,M.P., Dierich,A. and Sassone-Corsi,P. (2001) Altered behavioral rhythms and clock gene expression in mice with a targeted mutation in the Period1 gene. EMBO J., 20, 3967-3974.
31. Zheng,B., Albrecht,U., Kaasik,K., Sage,M., Lu,W., Vaishnav,S., Li,Q., Sun,Z.S., Eichele,G., Bradley,A. and Lee,C.C. (2001) Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell, 105, 683-694.
32. Lee,C., Weaver,D.R. and Reppert,S.M. (2004) Direct association between mouse period and ck1E is critical for a functioning circadian clock. Mol. Cell. Biol., 24, 584-594.
33. Hrushesky,W.J.M. and Bjarnason,G.A. (1993) Circadian cancer therapy. J. Clin. Oncol., 11, 1403-1417.
34. Leví,F. (1999) Cancer chronotherapy. J. Pharm. Pharmacol., 51, 891-898.
35. Mormont,M.C., Waterhouse,J., Bleuzen,P., Giacchetti,S., Jami,A., Bogdan,A., Lellouch,J., Misset,J.L., Touitou,Y. and Lévi,F. (2000) Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin. Cancer Res., 6, 3038-3045.
36. Lévi,F. (2001) Circadian chronotherapy for human cancers. Lancet Oncol., 2, 307-315.
37. Focan,C. (1995) Circadian rhythms and cancer chronotherapy. Pharmacol. Ther., 67, 1-52.
38. Mormont,M.C. and Levi,F. (2003) Cancer chronotherapy: Principle, applications and perspectives. Cancer, 97, 155-169.
39. Clark,S.J. and Melki,J. (2002) DNA methylation and gene silencing in cancer: Which is the guilty party? Oncogene, 21, 5380-5387.
40. Menard,S., Pupa,S.M., Campiglio,M. and Tagliabue,E. (2003) Biologic and therapeutic role of HER2 in cancer. Oncogene, 22, 6570-6578.
41. Leung,W.K., Yu,J., Ng,E.K., To,K.F., Ma,P.K., Lee,T.L., Go,M.Y., Chung,S.C. and Sung,J.J. (2001) Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. Cancer, 91, 2294-2301.
42. Fu,L., Pelicano,H., Liu,J., Huang,P. and Lee,C. (2002) The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell, 111, 41-50.
43. Matsuo,T., Yamaguchi,S., Mitsui,S., Emi,A., Shimoda,F. and Okamura,H. (2003) Control mechanism of the circadian clock for timing of cell division in vivo. Science, 302, 255-259.